切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (04) : 316 -319. doi: 10.3877/cma.j.issn.2095-3224.2017.04.010

所属专题: 文献

综述

卵巢切除术在结直肠癌综合治疗中的研究进展
李群1, 黄镜1,()   
  1. 1. 100021 北京,国家癌症中心/中国医学科学院北京协和医学院肿瘤医院肿瘤内科
  • 收稿日期:2017-03-16 出版日期:2017-08-25
  • 通信作者: 黄镜

Research progress of oophorectomy in the combined modality therapy of colorectal cancer

Qun Li1, Jing Huang1,()   

  1. 1. Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
  • Received:2017-03-16 Published:2017-08-25
  • Corresponding author: Jing Huang
  • About author:
    Corresponding author: Huang Jing, Email:
引用本文:

李群, 黄镜. 卵巢切除术在结直肠癌综合治疗中的研究进展[J/OL]. 中华结直肠疾病电子杂志, 2017, 06(04): 316-319.

Qun Li, Jing Huang. Research progress of oophorectomy in the combined modality therapy of colorectal cancer[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(04): 316-319.

卵巢转移是结直肠癌转移的少见形式,预后差。卵巢转移灶相对于其他转移部位对化疗的敏感性更差,因此,卵巢切除术在结直肠癌综合治疗中的价值值得进一步探索,本文通过文献复习从手术切除卵巢转移灶和预防性卵巢切除2方面对其进行总结。一些回顾性研究结果显示对卵巢转移灶行积极的手术切除治疗可能对晚期结直肠癌患者的生存有益,仍迫切需要大样本前瞻性随机对照研究为手术治疗结直肠癌卵巢转移提供循证依据。考虑到结直肠癌患者卵巢转移的发生率非常低,有研究者并不支持积极地预防性切除卵巢,但对于更易存在卵巢微转移的部分筛选人群,行预防性卵巢切除则可能带来生存获益,值得进一步探索。

Ovarian metastases are uncommon in women with colorectal cancer (CRC) and harbor poor prognosis. Due to less sensitivity to systemic chemotherapy of ovarian metastases compared to extraovarian metastases, oophorectomy in the comprehensive treatment of CRC deserves further study. This study reviewed researches on oophorectomy in the comprehensive treatment of CRC and summarized form two aspects including ovarian metastatectomy and prophylactic oophorectomy. Retrospective researches had shown potential survival benefits from optimal ovarian metastatectomy in CRC patients with ovarian metastasis, but randomized prospective trials are urgently warranted. Because of the low incidence of ovarian metastases from CRC, prophylactic oophorectomy in colorectal cancer surgery was not recommended by some researchers. However, strictly selected patients with clinical findings suggestive of ovarian micrometastasis might obtain survival benefits by prophylactic oophorectomy, which deserves further study.

[1]
Ribeiro Gomes J, Belotto M, D′Alpino Peixoto R. The role of surgery for unusual sites of metastases from colorectal cancer: A review of the literature[J]. Eur J Surg Oncol, 2017, 43(1):15-19.
[2]
Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors[J]. Clin Epidemiol, 2012, (4):283-301.
[3]
Gonzalez M, Poncet A, Combescure C, et al. Risk factors for survival after lung metastasectomy in colorectal cancer patients: a systematic review and meta-analysis[J]. Ann Surg Oncol, 2013, 20(2):572-579.
[4]
Segelman J, Flöter-Rådestad A, Hellborg H, et al. Epidemiology and prognosis of ovarian metastases in colorectal cancer[J]. Br J Surg, 2010, 97(11):1704-1709.
[5]
Tan KL, Tan WS, Lim JF, et al. Krukenberg tumors of colorectal origin: a dismal outcome—experience of a tertiary center[J]. Int J Colorectal Dis, 2010, 25(2):233-238.
[6]
Goéré D, Daveau C, Elias D, et al. The differential response to chemotherapy of ovarian metastases from colorectal carcinoma[J]. Eur J Surg Oncol, 2008, 34(12):1335–1339.
[7]
Taylor AE, Nicolson VM, Cunningham D. Ovarian metastases from primary gastrointestinal malignancies: the Royal Marsden Hospital experience and implications for adjuvant treatment[J]. Br J Cancer, 1995, 71(1):92–96.
[8]
Lee SJ, Lee J, Lim HY, et al. Survival benefit from ovarian metastatectomy in colorectal cancer patients with ovarian metastasis: a retrospective analysis[J]. Cancer Chemother Pharmacol, 2010, 66(2):229-235.
[9]
Chung TS, Chang HJ, Jung KH, et al. Role of surgery in the treatment of ovarian metastases from colorectal cancer[J]. J Surg Oncol, 2009, 100(7):570-574.
[10]
Rayson D, Bouttell E, Whiston F, et al. Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma[J]. J Surg Oncol, 2000, 75(3):186–192.
[11]
McCormick CC, Giuntili RL, Gardner GJ, et al. The role of cytoreductive surgery for colon cancer metastatic to the ovary[J]. Gynecol Oncol, 2007, 105(3):791–795.
[12]
Ayhan A, Guvenal T, Salman MC, et al. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries[J]. Gynecol Oncol, 2005, 98(2):235-241.
[13]
车旭,单毅,周志祥, 等. 结直肠癌卵巢转移的外科治疗及预后分析[J]. 中华肿瘤杂志, 2007, 29(11):864-866.
[14]
Sakakura C, Hagiwara A, Yamazaki J, et al. Management of postoperative follow-up and surgical treatment for Krukenberg tumor from colorectal cancers[J]. Hepatogastroenterology, 2004, 51(59):1350-1353.
[15]
Jiang R, Tang J, Cheng X, et al. Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors[J]. Eur J Surg Oncol, 2009, 35(1):92-97.
[16]
Garrett CR, George B, Viswanathan C, et al. Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary[J]. Clin Colorectal Canc, 2012, 11(3):191-194.
[17]
Birnkrant A, Sampson J, Sugarbaker PH. Ovarian metastasis from colorectal cancer[J]. Dis Colon Rectum, 1986, 29(11):767-771.
[18]
Mrad K, Marice P, Fabre A, et al. Krukenberg tumor: a clinico-pathological study of 15 cases[J]. Ann Pathol, 2000, 20(3):202-206.
[19]
Sielezneff I, Salle E, Antoine K, et al. Simultaneous bilateral oophorectomy does not improve prognosis of postmenopausal women undergoing colorectal resection for cancer[J]. Dis Colon Rectum, 1997, 40(11):1299-1302.
[20]
Tentes A, Markakidis S, Mirelis C, et al. Oophorectomy during surgery for colorectal carcinoma[J]. Tech Coloproctol, 2004(Suppl 1):s214-216.
[21]
Liang JT, Lai HS, Wu CT, et al. Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer[J]. Ann Surg Oncol, 2007, 14(7):1991-1999.
[22]
Graffner HO, Alm PO, Oscarson JE. Prophylactic oophorectomy in colorectal carcinoma[J]. Am J Surg, 1983, 146(2):233-235.
[23]
Young-Fadok TM, Wolff BG, Nivatvongs S, et al. Prophylactic oophorectomy in colorectal carcinoma: preliminary results of a randomized, prospective trial[J]. Dis Colon Rectum, 1998, 41(3):277-283.
[24]
MacKeigan JM, Ferguson JA. Prophylactic oophorectomy and colorectal cancer in premenopausal patients[J]. Dis Colon Rectum, 1979, 22(6):401-405.
[25]
Cutait R, Lesser ML, Enker WE. Prophylactic oophorectomy in surgery for large-bowel cancer[J]. Dis Colon Rectum, 1983, 26(1):6-11.
[26]
Omranipour R, Abasahl A. Ovarian metastases in colorectal cancer[J]. Int J Gynecol Cancer, 2009, 19(9):1524-1528.
[1] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[2] 易柏成, 李旭光, 王容容, 王新璇. 数字化3D打印导板应用于上前牙钙化根管治疗2例[J/OL]. 中华口腔医学研究杂志(电子版), 2024, 18(06): 385-390.
[3] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[4] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[5] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[6] 刘柏隆, 周祥福. 压力性尿失禁阶梯治疗的项目介绍[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 125-125.
[7] 刘柏隆. 女性压力性尿失禁阶梯治疗之手术治疗方案选择[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2025, 19(01): 126-126.
[8] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[9] 陈伟杰, 何小东. 胆囊癌免疫靶向治疗进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 763-768.
[10] 中国抗癌协会, 中国抗癌协会大肠癌专业委员会. 中国恶性肿瘤整合诊治指南-肛管癌(2024 版)[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 441-449.
[11] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[12] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[13] 吴天宇, 刘子璇, 杨浦鑫, 贾思明, 丁凯, 程晓东, 李泳龙, 陈伟, 吕红芝, 张奇. 腰椎间盘突出症保守治疗进展[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 379-384.
[14] 崔军威, 蔡华丽, 胡艺冰, 胡慧. 亚甲蓝联合金属定位夹及定位钩针标记在乳腺癌辅助化疗后评估腋窝转移淋巴结的临床应用价值探究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 625-632.
[15] 王誉英, 刘世伟, 王睿, 曾娅玲, 涂禧慧, 张蒲蓉. 老年乳腺癌新辅助治疗病理完全缓解的预测因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 641-646.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?